ID: ALA2370889

Max Phase: Preclinical

Molecular Formula: C41H71N13O10

Molecular Weight: 906.10

Molecule Type: Protein

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CCO)NC(=O)[C@@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)CNC)C(C)C)[C@@H](C)CC)C(=O)O

Standard InChI:  InChI=1S/C41H71N13O10/c1-8-23(5)32(38(61)50-28(18-25-19-45-21-47-25)39(62)54-16-11-13-29(54)36(59)53-33(40(63)64)24(6)9-2)52-35(58)27(14-17-55)49-37(60)31(22(3)4)51-34(57)26(48-30(56)20-44-7)12-10-15-46-41(42)43/h19,21-24,26-29,31-33,44,55H,8-18,20H2,1-7H3,(H,45,47)(H,48,56)(H,49,60)(H,50,61)(H,51,57)(H,52,58)(H,53,59)(H,63,64)(H4,42,43,46)/t23-,24-,26-,27-,28-,29-,31-,32-,33-/m0/s1

Standard InChI Key:  ITQPYZPLFYQRFX-ZJZWOIHQSA-N

Associated Targets(non-human)

Angiotensin II receptor 1735 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Angiotensin II receptor (AT-1) type-1 1480 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: ProteinTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 906.10Molecular Weight (Monoisotopic): 905.5447AlogP: -2.66#Rotatable Bonds: 28
Polar Surface Area: 357.55Molecular Species: ZWITTERIONHBA: 12HBD: 12
#RO5 Violations: 3HBA (Lipinski): 23HBD (Lipinski): 14#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.88CX Basic pKa: 13.85CX LogP: -4.75CX LogD: -5.83
Aromatic Rings: 1Heavy Atoms: 64QED Weighted: 0.02Np Likeness Score: 0.13

References

1. Matsoukas JM, Agelis G, Wahhab A, Hondrelis J, Panagiotopoulos D, Yamdagni R, Wu Q, Mavromoustakos T, Maia HL, Ganter R..  (1995)  Differences in backbone structure between angiotensin II agonists and type I antagonists.,  38  (23): [PMID:7473593] [10.1021/jm00023a005]

Source